It is said to be inherited and may show up later in life. Untreated glaucoma can result in permanent loss of vision, whereas with treatment it can slow down the pace of damage.
Congenital glaucoma or infant glaucoma means that you are born with it.
Adults over 40 are more susceptible to glaucoma but infants, children and young adults also have chances of developing this disease.
However, the permanent antidote is not available for glaucoma. It can be controlled with the help of eye drops, laser surgery, trabeculoplasty, iridotomy, cyclophotocoagulation, and microsurgery. Open-angle glaucoma is often cured with several combinations of laser, microsurgery, trabeculoplasty, and various eye drops. Although doctors in the U.S. start the diagnosis with medications, yet in some case, early microsurgery or laser surgery have proved effective for some people.
The World Health Organization (WHO) identified glaucoma as the second leading cause of blindness. For those who don’t know what glaucoma is, it is a condition that damages the optic nerve of the eyes due to pressure buildup inside the eye and deteriorates with time.
The reality of this “Future Stent”
A study published by Bright Focus Foundation people of African-American, Irish, Japanese, Russian, Scandinavian, or Inuit descendent tend to get it more often. Also, individuals who have a family history of glaucoma, history of diabetes, poor vision, have had trauma to the eyes or eyes, or have taken steroids like prednisone are at the risk of glaucoma.
In some cases, surgical intervention is indispensable. Conventionally, surgery comprises trabeculectomy, i.e. partial removal of eye’s trabecular meshwork and contiguous tissues or the placement of tube shunts. Mostly these techniques are successful but ophthalmologists are working on less intrusive techniques.
Thinking of having something implanted in your eye or having a surgical procedure on your eye might give you goosebumps.
Yes, it may sound scary but actually, it is far better than traditional methods. The treatment takes only a couple of minutes and is significantly less complicated than the traditional surgery.
The discussed treatment will seemingly take the form of inoculation that can be handled at the doctor’s office. Even though it will be injected in the eye, the resultant pain and discomfort will be minimal.
Additionally, the effects are also instantaneous, slashing the need for eye drops. This method can soon prove as a sustainable answer for the patients who are dissatisfied with the results of conventional surgical remedies, or who are in need of the minimally intrusive procedure.
The gel stent surgery is advised to use in addition to cataract surgery in order to reduce intraocular pressure (IOP) with moderate to mild open-angle glaucoma with ocular hypotensive medication.
The device Is not recommended for patients suffering from thyroid eye disease, retrobulbar tumor, Sturge-Weber Syndrome or any other type of condition that can potentially elevate episcleral venous pressure.
The patients are suggested to stay under observation post-operation for proper upkeep of intraocular pressure. The safety and effectiveness of the gel stent have not been verified as an option in the patients with the following conditions:
- Children whose eyes were subjective to a grave prior trauma, with an abnormal anterior segmentation, or with chronic inflammation.
- Pseudophakic patients with glaucoma
- Patients with pseudoexfoliative glaucoma, uveitis, and pigmentary glaucoma.